Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance

Sanofi-Aventis Names Covance its R&D Partner as part of US$2.2 Billion Agreement -

PRINCETON, New Jersey, September 30, 2010 – Covance Inc. (NYSE: CVD) today announced the signing of definitive
agreements with sanofi-aventis (EURONEXT: SAN and NYSE: SNY) for Covance to
become sanofi-aventis' R&D partner. Over the next ten years, Covance expects
to provide drug development services to [...]

Concentric Medical Announces Initiation of the First Stentriever(TM) Study in Europe

MOUNTAIN VIEW, California, September 30, 2010 – Concentric Medical, Inc., the global leader in acute ischemic stroke
intervention, today announced the start of the TREVO Study. The first
patients were enrolled and successfully treated at the Hospital Clinic de
Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco.

The TREVO Study [...]

Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period

DUBLIN, September 30, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that shareholders of Movetis NV have
tendered 99.18% of the shares of Movetis (Euronext Brussels: MOVE) during the
initial acceptance period of the tender offer which closed on September 27,
2010. The shares tendered into the tender offer are expected to [...]

Care Home Regulator Abandons Star Ratings – but Closes the Worst Homes

LONDON, September 30, 2010 – BestCareHome.co.uk, the care home comparison website, announced today
that it will continue to award and publish star ratings, even as the
regulator of Care Homes moves to abandon them on its own website.

The Care Quality Commission (CQC) stopped awarding star ratings at the
end of June, and after [...]

Campaign Launched by EPDA to Highlight Overlooked Symptoms of Parkinson’s Disease

New Life With Parkinson's – Non-Motor Symptoms Campaign Builds on Parkinson's Awareness Campaign

GLASGOW, Scotland, September 30, 2010 – Today the European Parkinson's Disease Association (EPDA)
announces the launch of its pan-European awareness campaign, Life with
Parkinson's – Non-Motor Symptoms at the 2nd World Parkinson Congress in
Glasgow.
Recent surveys have revealed that close to [...]

Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors

CALGARY, Canada, September 30, 2010 – Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces
that Mr. Kenneth Zuerblis has been appointed to the Company's Board of
Directors. Recently Mr. Zuerblis served as the Chief Financial Officer and
Senior Vice President of ImClone Systems Inc., prior to its acquisition by
Eli Lilly.

"I was initially attracted [...]

Inaugural Pharma Exchange Conference Produced by Informex to Draw Together Milwaukee, Wisconsin Chemical Industry

First in a series of pharma conferences seeks to build business relationships and encourage sharing and collaboration within regional marketplaces

PRINCETON, New Jersey, September 30, 2010 – Informex (www.informex.com), the leading meeting place for buyers
and sellers of high-value chemistry for a broad range of applications, today
announced that its first ever Pharma Exchange Conference will occur [...]

Stroz Friedberg Amplifying Growth with US$115MM New Mountain Capital Investment

NEW YORK, September 30, 2010 – Stroz Friedberg's unsurpassed expertise in managing digital risk and
uncovering digital evidence has helped attract a US$115 million investment
from New Mountain Capital to fuel and accelerate the company's growth.

"This investment is with the perfect partner and happens at the perfect
time," says Eric Friedberg (
www.strozfriedberg.com/professionals/xprProfessionalDetails1.aspx?xpST=ProfessionalDetail&professional=4
), Co-President [...]

The Harley Medical Group Sees Steady Increase in Breast Reduction Procedures

LONDON, September 30, 2010 – The Harley Medical Group reports that it has seen a steady increase in
breast reduction procedures in the UK. With breast surgery still top of the
ops in the cosmetic surgery field, wanting to appear slimmer is an
increasingly common motivator for women having breast reductions. A smaller
looking frame helps towards the [...]

First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products

cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of [...]

First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products

cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of [...]

Hospira Names Svend Andersen to Lead Europe, Middle East and Africa

LEAMINGTON SPA, England, October 4, 2010 – Hospira (NYSE: HSP), a global specialty pharmaceutical and medication
delivery company, announced today that Svend Andersen has been named
corporate vice president and president, Europe, Middle East and Africa
(EMEA). In this capacity, he will be responsible for developing strategy,
delivering growth and attaining market leadership in the EMEA region.
Andersen, 48, [...]

Almac’s North American Headquarters Opens its Doors for Audits

SOUDERTON, Pennsylvania, October 4, 2010 – Almac has officially begun hosting customer audits onsite at the new
North American Headquarters. Nine companies have already been given a tour of
the new facility by Business Development staff. Almac has also hosted three
of five "audit open houses" in which multiple customers are free to attend.
The audits have been [...]

Elsevier Launches New Journal: Developmental Cognitive Neuroscience

A Journal for Cognitive, Affective and Social Developmental Cognitive Neuroscience

OXFORD, England, October 4, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce the launch of a
new journal, Developmental Cognitive Neuroscience. (
www.elsevier.com/wps/find/journaldescription.cws_home/722734/descripti
on) Published quarterly, print copies of the first issue will be available at
the Society for [...]

Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award

NEUCHATEL, Switzerland, October 4, 2010 – Elsevier Properties SA today congratulated its Research and Development
Director, Professor Dr. Alexander (Sandy) Lawson, for receiving the 2011
Herman Skolnik Award. Presented by the American Chemical Society (ACS)
Division of Chemical Information (CINF), the award recognizes outstanding
contributions to and achievements in the theory and practice of chemical
information science and related [...]

Medtronic Announces Collaboration With Tissuemed for Exclusive Distribution of Innovative Neurosurgical Film

MINNEAPOLIS, October 4, 2010 – Medtronic, Inc. (NYSE: MDT) today announced it will distribute Obex
NeuroFilm(TM) Cerebrospinal Fluid Barrier in markets outside the US in
collaboration with Tissuemed, a leading company in the research, development,
design and manufacture of products utilizing adhesive polymer technology for
medical applications.

Under the terms of its agreement with Tissuemed, [...]

Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, October 4, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced that the Merci Retriever(R) has
recently received both product and procedure reimbursement from the Japanese
Ministry of Health, Labor and Welfare. The Merci Retriever is a
catheter-based medical device that physicians at stroke centers [...]

ProteoTech and Tasly Pharmaceuticals Announce Alzheimer’s Disease Drug Development Agreement for Exebryl-1(R)

Potential disease-modifying Alzheimer's treatment targeting beta-amyloid and tau protein advancing through collaboration between ProteoTech Inc. and major Chinese company, Tasly Pharmaceuticals.

KIRKLAND, Washington, October 4, 2010 – Tasly Pharmaceutical Co., Ltd. (Tianjin, China) and ProteoTech, Inc.
(Kirkland, WA, USA) today announced an agreement to co-develop ProteoTech's
novel small molecule therapeutic, Exebryl-1(R), for the treatment of
mild-to-moderate Alzheimer's disease. [...]

Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level

AMSTERDAM, October 4, 2010 – On Tuesday, September 28, Elsevier released the results of a
"Future of Search and Discovery" opinion survey that was designed to provide
a "quick pulse" of the attitudes of researchers through an informal online
opinion poll. While it was not a scientific research study nor labeled as
such in the release, we should [...]

BridgePoint Medical(R), Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss(R) and Stingray(R) CTO Recanalization System

MINNEAPOLIS, October 4, 2010 – BridgePoint Medical, Inc., a medical device company focused on coronary
and peripheral catheter-based systems for chronic total occlusion (CTO)
recanalization, announced the completion of the FAST-CTOs study.
BridgePoint's 16 center, 147 patient U.S. FAST-CTOs (Facilitated Antegrade
Steering Technique for the treatment of Chronic Total Occlusions) study was
designed to assess the safety and effectiveness [...]

Sirius Genomics Receives NRC-IRAP Funding for Development of New Biomarkers

VANCOUVER, October 5, 2010 – Sirius Genomics, a developer of companion diagnostics, announced today
that it has signed its second Contribution Agreement with the National
Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

This research funding will be applied to discovery of genomic biomarkers
that are predictive of patient response to therapeutics used [...]

Blood Pressure Pills More Effective When Taken at Night

New Research Which Shows That Timing Blood Pressure Medication With a Patient's Body Clock Make it More Effective and Offers Greater Protection Against the Occurrence of Heart Attacks and Strokes is Set to Change the Hypertension Treatment for Hundreds of Millions of People Worldwide

NEW YORK, October 5, 2010 – Chronobiology International – the international [...]

World-Check Launches Best Practice Iran Sanctions Solution – Two New Products to Help Clients Identify Iran Regulatory and Reputational Risk

Market Leader Dedicates its Unparalleled Resources to Help its 4,500+ Clients Meet Their New Requirements

LONDON, October 5, 2010 – World-Check today announced the launch of its Iran Economic Interest
(IEI) solution following a raft of new international legislation including
the U.S. Government's Comprehensive Iran Sanctions, Accountability and
Divestment Act (CISADA) of July 2010, U.N. Security Council Resolution [...]

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer’s Disease

BROOMFIELD, Colorado, October 5, 2010 – Accera, Inc., a medical research and development company delivering
breakthrough therapies for serious diseases such as Alzheimer's disease (AD),
announced today that Thomas Werner, Ph.D., has been appointed President and
CEO. Concurrently with Dr. Werner's appointment, the U.S. Food and Drug
Administration (FDA) has accepted Accera's Investigational New Drug (IND)
application to conduct [...]

Nobel Prize for Scientist Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online

CAMBRIDGE, England, October 5, 2010 – Elsevier congratulates Cambridge scientist and Editor Emeritus of
Reproductive BioMedicine Online (RBMOnline), Robert G. Edwards, who has been
awarded with the 2010 Nobel Prize in Medicine for the development of in-vitro
fertilisation (IVF), a breakthrough that has helped millions of infertile
couples worldwide to have children. Professor Edwards, 85, started working on
IVF, [...]

Amsterdam Molecular Therapeutics Launches Equity Offering of up to EUR 15 Million

Not for release, publication or distribution in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or South Africa or to US persons. This announcement is not a prospectus and is not an offer for sale of securities in the United States, Canada, South Africa, Australia, Japan or [...]

Ground Zero Pharmaceuticals Announces Expansion of Global Consulting in Somatic Cell Therapies

IRVINE, California, October 5, 2010 – GZP is pleased to announce that it has expanded its capabilities for
strategic regulatory and product development support of gene therapy and
somatic cell therapies, including treatment vaccines for cancer and other
serious or life-threatening diseases. New senior associates with expertise in
manufacturing and clinical development in these expanding areas allow GZP [...]

Elsevier Introduces Article-Based Publishing to Increase Publication Speed

Final and Citable Articles are Published Without Needing to Wait Until a Journal Issue is Complete; Speeding the Publication Process by an Average of 7 Weeks

AMSTERDAM, October 6, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and solutions, announced today the launch of
Article-Based Publishing — a new publishing model that [...]

Amsterdam Molecular Therapeutics Successfully Raised EUR 14.3 m Through an Equity Issue

AMSTERDAM, October 6, 2010 – Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext:
AMT) announces today that it has successfully raised EUR 14.3 m in gross
proceeds through a private placement of new shares with institutional
investors, other qualifying investors who subscribed for at least EUR 50,000
per investor in various jurisdictions and the members of the Board of
Management [...]

Milestone Ruling for Alzheimer’s Disease Patients Announced

LONDON, October 7, 2010 – The National Institute for Health and Clinical Excellence (NICE) has
today announced new draft guidance which represents a significant step
towards ensuring patients with Alzheimer's disease in England and Wales
receive treatment for their condition, from the early stages of disease.

New draft NICE guidance released today recommends that
acetylcholinesterase [...]

Durban Commitment Targets Eye Care Crisis

DURBAN, South Africa, October 7, 2010 – The world is suffering a global eye care crisis according to world
leaders in vision health and development who attended the World Congress on
Refractive Error in Durban, South Africa.

A staggering 670 million are avoidably blind or vision impaired because
they don't have simple vision correction [...]

International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women

New Treatment Recommendations Urge Women and Doctors to Overcome the Taboo of Postmenopausal Vaginal Atrophy

LONDON, October 7, 2010 – To mark World Menopause Day on 18th October 2010, the International
Menopause Society (IMS) is launching new Recommendations for the management
of postmenopausal vaginal atrophy, a distressing condition that will affect
up to half of women after menopause.[1] [...]

Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment

CRAIGAVON, Northern Ireland, October 7, 2010 – The need for green, economic, robust and scaleable processes
for the synthesis of chiral APIs and intermediates prompted Almac (CPHI Booth
4F32) to build and fully integrate a biocatalysis group into its service
portfolio. Last year Almac launched carbonyl reductase, transaminase,
hydrolase, nitrilase, and nitrile hydratase enzyme screening kits and is
continuing [...]

IDEV Technologies Completes US$46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor

Proceeds to Fund Clinical Trials, New Product Development, Continued Revenue Growth

WEBSTER, Texas, October 7, 2010 – IDEV Technologies, Incorporated (IDEV), an emerging leader in the
development and commercialization of minimally invasive medical technologies,
today announced that it has completed a US$46 million Series D round of
financing, with Piper Jaffray & Co.'s Merchant Banking Fund (PJC Capital [...]

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets

Updated Study Results to be Presented on ALK inhibitor (PF-02341066) and Pan-HER Inhibitor (PF-00299804) in Non-Small Cell Lung Cancer

NEW YORK, October 7, 2010 – Pfizer Oncology will present new data across its portfolio representing
novel approaches to researching treatments for patients with rare and
difficult-to-treat cancers. These results will be presented at the 35th
European Society for [...]

2nd Call for DigestScience European Projects for a Total of 500,000 Euros

The Manipulation of Intestinal Flora: A New Challenge in the Treatment of Digestive Tract Diseases…

LOOS, France, October 7, 2010 – The DigestScience Foundation is launching a European call for tenders to
support cutting-edge research into digestive tract diseases: "Manipulation of
intestinal flora in health and disease : areas of interest include
genetically selected/modified organisms, virus, phages, parasites, [...]

Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis

Results Presented at the Annual Meeting of the European Academy of Dermatology and Venereology in Gothenburg, Sweden

NEW YORK, October 7, 2010 – Pfizer Inc. (NYSE: PFE) today announced that data from a Phase 2 efficacy
and safety study of tasocitinib (proposed INN name for CP-690,550), the
company's investigational oral JAK inhibitor, met its primary endpoint of [...]

Philips Introduces New Patient Monitoring System Enabling Easy Access to Patient Information and Facilitating Effective Care Delivery

ANDOVER, Massachusetts, October 7, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the
IntelliVue MX800 patient monitoring system, a new dimension in patient care
that provides immediate access to comprehensive patient information directly
at the monitor. In addition to displaying and recording traditional data such
as patient vital signs, the IntelliVue MX800 offers direct access [...]

Majestic MRSS Adds Focus Vision in Singapore

MUMBAI, India, October 7, 2010 – MMRSS which has been expanding its geographic footprint over the past 5
years announced the opening of qualitative research facility in Singapore.

The state of the art one way mirror facility is Focus Vision enabled and
is large enough to host Super Focus Groups (Super FG's). The [...]

Novocure Reports Data Showing TTF Therapy in Combination With Chemotherapy Has the Potential to Increase Overall Survival for Patients With Advanced Non-Small Cell Lung Cancer

Data Presented Today at the 35th European Society for Medical Oncology Congress

MILAN, October 10, 2010 – Novocure reported today that patients with advanced non-small cell lung
cancer (NSCLC) achieved a significant increase in survival time when tumor
treating fields (TTF) therapy was added to chemotherapy, as compared to
previously reported outcomes for patients receiving chemotherapy alone. Dr.
Miklos [...]

Eisai’s Eribulin Mesylate Maintains Overall Survival Benefit in Patients With Metastatic Breast Cancer, Irrespective of Tumour Hormone Receptor Status

Results From the EMBRACE Study Reinforce Efficacy of Eribulin Across Several Patient Sub-Groups

MILAN, October 10, 2010 – Further results from the Phase III EMBRACE study presented today at the
European Society of Medical Oncology (ESMO) congress showed that Eisai's
eribulin mesylate maintained an overall survival (OS) benefit compared with
Treatment of Physician's Choice (TPC) in metastatic breast [...]

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

WOBURN, Massachusetts, October 12, 2010 – ArQule, Inc. (NASDAQ: ARQL) and Daiichi Sankyo Co., Ltd. (TSE
4568) today announced the expansion of their research, development and
license agreement for the discovery of novel kinase inhibitors in the field
of oncology. This expanded agreement establishes a third therapeutic target,
with an option for a fourth, in the field of [...]

BiondVax Begins Phase IIa Study for Universal Flu Vaccine

NESS ZIONA, Israel, October 11, 2010 – BiondVax Pharmaceuticals Ltd. (TASE: BNDX) (www.biondvax.com/), an
Israeli biopharmaceutical company at the forefront of global efforts towards
the development of a Universal Influenza Vaccine, today announced that it has
begun to immunize subjects in a Phase IIa clinical trial of the
Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the
safety [...]

Global Experts Debate Solutions for Preventing Healthcare Acquired Infections at the 2010 International Conference of The Hospital Infection Society

ASP Sponsors Educational Symposium to Strengthen Infection Prevention Efforts and Promote Better Patient Care

LONDON, October 11, 2010 – At this week's international conference of the Hospital Infection Society
in Liverpool, United Kingdom, the world's leading experts in healthcare
acquired infections will gather to share their latest research and discuss
new ways of combatting diseases like MRSA and [...]

Shire Appoints Philip J. Vickers, PhD as Senior Vice President of Research & Development for Human Genetic Therapies Business

NYON, Switzerland and CAMBRIDGE, Massachusetts, October 11, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that Philip J. Vickers, PhD, has
been appointed Senior Vice President of Research & Development (R&D) for its
Human Genetic Therapies (HGT) business. In this position, Dr. Vickers will be
responsible for leading global R&D for [...]

Abiraterone Acetate Significantly Improved Overall Survival for Patients With Metastatic Advanced Prostate Cancer

Note: Data in This Release Correspond to ESMO Abstract LBA5
BEERSE, Belgium, October 11, 2010 – Results from a pre-specified interim analysis of a randomised,
placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients
treated with the investigational agent abiraterone acetate plus low dose
prednisone/prednisolone showed a significant improvement in overall survival
compared to patients treated with prednisone/prednisolone plus placebo. [...]

Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia

BOZEN, Sud-Tirol, Italy, October 11, 2010 – Health Robotics today announced that it recently signed exclusive
distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT
world-leading technologies in seven new European countries with regional
industry leaders Newico and Apta Medica, rapidly continuing on its worldwide
quest to pervasively provide safe and cost-effective Intravenous (IV)
Admixture Compounding Automation to hospitals all [...]

The Harley Medical Group Announces Rise in Breast Surgery Procedures in Ireland

DUN LOAGHAIRE, Ireland, October 11, 2010 – The Harley Medical Group, Ireland's leading cosmetic surgery provider,
has revealed breast surgery is top of the ops for the 23rd year running and
the fastest growing sector of cosmetic surgery. The Harley Medical Group has
seen a positive increase on last year's enquiries. While breast reductions
are becoming more popular [...]

Final Analysis of Landmark IPASS Study Confirms That IRESSA (Gefitinib) is a Valuable Option for the First-Line Treatment of Patients With Advanced NSCLC With EGFR Activating Mutations

MILAN, October 11, 2010 – This press release has been made available on worldwide (excluding US)
press communication media for the benefit of correspondents writing for the
medical professional press. Differing national legislation, codes of
practice, medical practice etc mean that you should contact your local AZ
press office to obtain information designed for use in your country.
Not [...]

Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874)

Data Compares Briakinumab (ABT-874) to Etanercept, Methotrexate and Placebo in Psoriasis

ABBOTT PARK, Illinois, October 11, 2010 – In four separate pivotal clinical studies presented on Friday, a greater
percentage of moderate to severe chronic plaque psoriasis patients treated
with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874),
achieved 75 percent or better skin clearance rates than those treated with
etanercept [...]

HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event

Award goes to the company for pioneering business in developing areas of Belfast.

STORMONT, BELFAST, Northern Ireland, October 11, 2010 – HeartSine Technologies, Inc. (www.heartsine.com) was honored with
the Belfast Ambassador Award at the sixth annual Belfast Business Top 50
event in Stormont, Belfast. The award was presented to the company by the
Belfast Media Group (belfastmedia.com) for [...]

Safety Confirmed of Breast Augmentation With Autologous Fat Stem Cells

Stem Cell-Enriched Autologous Fat Makes Permanent Natural Breast Enlargement

VIENNA, October 12, 2010 – Since 2003, breast augmentation utilizing stem cells from autologous fat
has been developed enabling silicon-free breast reconstruction following
cancer surgery. Till now though, it was unclear whether this might reactivate
the cancer again. However, University of Pittsburgh researchers led by Prof.
Albert Donnenberg have now [...]

Elsevier Announces Publishing of The American Journal of Pathology (AJP) on Behalf of the American Society for Investigative Pathology (ASIP)

PHILADELPHIA, October 12, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce that as of January
2011 Elsevier will publish The American Journal of Pathology (AJP) in
partnership with the American Society for Investigative Pathology (ASIP).

The American Journal of Pathology is the official [...]

Elsevier Announces Publishing of The Journal of Molecular Diagnostics, on Behalf of the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP)

PHILADELPHIA, October 12, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce that as of January
2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in
partnership with the Association for Molecular Pathology (AMP) and the
American Society for Investigative Pathology (ASIP).

The Journal [...]

Sirius Genomics and Golden Helix Collaborate on Companion Diagnostic Development

VANCOUVER and BOZEMAN, Montana, October 12, 2010 – Sirius Genomics, a developer of companion diagnostics, and Golden Helix,
a global leader in genetic analysis solutions, announced today a
collaboration under which Golden Helix will apply its expertise and
technologies in SNP and copy number variant analysis and predictive modeling
to advance development of Sirius' diagnostic pipeline.

[...]

One Month Until First Worldwide NET Cancer Awareness Day on November 10, 2010

1st Global Call-to-Action at www.netcancerday.org
NEW YORK, October 12, 2010 – The World NET Community announces the first Worldwide NET Cancer
Awareness Day on November 10, 2010 to raise awareness about cancers called
neuroendocrine tumors (NETs) and the need for timely detection and diagnosis.
More than 90% of all NET patients are incorrectly diagnosed and initially
treated for the [...]

Goodmans Solicitors Rebrand

LIVERPOOL, England, October 13, 2010 – Leading medical negligence and personal injury solicitors, Goodmans Law
(www.goodmanslaw.co.uk/) has completed a rebranding process to
complete their transition to a specialist medical negligence and personal
injury law firm.

Goodmans Law, based in Liverpool, has evolved into one of the largest
specialist firms in this area of law. Goodmans … Read : Goodmans Solicitors Rebrand.

Shire Acquires 99.21% of the Shares of Movetis N.V. and Announces Commencement of Squeeze-Out Tender Period

DUBLIN, October 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its wholly owned subsidiary Shire
Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on
October 12, 2010, following a successful tender offer launched in September
2010.

As previously announced, Shire will proceed with a …. Read the original article  : here.

New Line of Neonatal Blood Pressure Supplies Demonstrates Philips’ Commitment to Patient Safety

ANDOVER, Massachusetts, October 13, 2010 – Today Royal Philips Electronics (NYSE: PHG, AEX: PHI) launched its newest
line of neonatal blood pressure solutions. As the global leader in neonatal
monitoring, Philips designed the new line of neonatal cuffs, air hoses, and
upgrade kits specifically to prevent tragic misconnection errors that can
cause harm to the most vulnerable of … Read more : New Line of Neonatal Blood Pressure Supplies Demonstrates Philips' Commitment to Patient Safety.

Cell Biosciences to Acquire Convergent Bioscience

SANTA CLARA, California, October 13, 2010 – Cell Biosciences, Inc. today announced that it has entered into a
definitive agreement to acquire Convergent Bioscience Ltd. for approximately
U.S. $12 million in cash. The transaction is expected to close by the end of
October, 2010.

Convergent Bioscience was founded in 1995 and employs 45 people,
primarily …. Original article  : Cell Biosciences to Acquire Convergent Bioscience.

Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters

SOUDERTON, Pennsylvania, October 13, 2010 – Almac announced today that its Clinical Technologies division has
successfully moved into the Almac Group's new North American Headquarters.
After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008,
the drug development firm has now completed the first phase of relocating
employees from three Almac business units to the … Read more »»».

Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco

SAN FRANCISCO, October 13, 2010 – Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and
"The Pink Sheet," today announced the agenda for Windhover's 2nd PharmAsia
Summit
(www.windhover.com/windhover/content/conferences/pharmasia.aspx)
(Oct. 25-26). This year's Summit will bring top biopharma leaders from
Asia and the U.S. to San Francisco to share what works and what doesn't in
China, India, Japan and the …. Original article  : Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco.

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna

Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research

OOSTERHOUT, Netherlands, October 13, 2010 – Luminex Corporation (Nasdaq: LMNX), today announced that it will host
Planet xMAP Europe 2010, its annual European multiplexing technology
symposium, October 20-21, 2010, at The Hofburg in Vienna, Austria. The event
will feature scientific … Read more >>>.

Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award

LONDON, October 13, 2010 – The 2010 Frost & Sullivan Europe Product Line Strategy Award in
Fingerprint Verification Components and Systems is presented to Fingerprint
Cards AB (FPC).

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"For more than a decade, FPC has been operating in the biometrics
industry with the prime … Read more : Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award.

PneumRx, Inc. Announces CE Mark Approval for Its RePneu(R) Lung Volume Reduction Coil (LVRC(TM)) System

MOUNTAIN VIEW, California, October 13, 2010 – PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to
bringing innovation and improvements to the treatment of lung disease, today
announced that it has received CE Mark approval for its RePneu Lung Volume
Reduction Coil (LVRC) System to treat the later stages of emphysema.

The RePneu LVRC … Read more >>>.

550 People Across Europe Will Die Today From a Preventable Lung Disease

On World Spirometry Day, Doctors Urge Regular "MOT Tests for the Lungs"

LONDON, October 14, 2010 – With new data revealing 23 Europeans die each hour[i] from a preventable
lung condition, the European Respiratory Society (ERS) is calling on people
across Europe to get their lungs tested on the first ever World Spirometry
Day – 14th October.
…. Read the original article  : 550 People Across Europe Will Die Today From a Preventable Lung Disease.

Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver

Poster presentation scheduled at AASLD November 2nd
SAN DIEGO, October 14, 2010 – Vital Therapies, Inc., (VTI) today announced that a poster is being
presented at the American Association for the Study of Liver Diseases (AASLD)
meeting in Boston on Tuesday, November 2nd. It confirms that previously
reported findings of improved transplant free survival (TFS) in Chinese
subjects with … Original article on : Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver.

DaTSCAN(TM) (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimer’s Disease

European Federation of the Neurological Societies Cites Utility of DaTSCAN in Differentiating Alzheimer's Disease from Dementia with Lewy Bodies

PRINCETON, New Jersey, October 14, 2010 – GE Healthcare, a unit of General Electric Company (NYSE: GE), today
announced that DaTSCAN(TM) (ioflupane I 123 injection), a radiopharmaceutical
agent intended for use with single photon emission computed tomography
(SPECT) imaging …. Source  : Gaea News Network.

The World Market for Diabetes Treatments Now Available at ReportsandReports

ReportsandReports Announces it Will Carry The World Market for Diabetes Treatments Research Report in its Store

DALLAS, October 14, 2010 – Browse the complete Report on:
www.reportsandreports.com/reports/35297-the-world-market-for-diabetes-
treatments.html
This Kalorama Information report , The World Market for Diabetes
Treatments, provides market estimates and forecasts for the world market for
diabetes treatments. The diabetes market is one … Read : The World Market for Diabetes Treatments Now Available at ReportsandReports.

First CyberKnife(R) System in Clinical Use in Czech Republic

Major Czech Academic Center Expands Care to Offer Radiosurgery
SUNNYVALE, California, October 14, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced that the first CyberKnife Robotic Radiosurgery
System in Czech Republic is now treating cancer patients at the University
Hospital of Ostrava (UHO) Clinic of Oncology.

The … Read more »».

Teva UK Limited Comments on Department of Health Generic Substitution Outcome

CASTLEFORD, England, October 15, 2010 – Teva UK Limited, the UK's leading manufacturer of generic medicines, has
today commented on the Department of Health's (DH) decision not to implement
generic substitution in primary care.

Although deciding not to go ahead with generic substitution as the
original proposals stood, DH has indicated that it will … Read the original article on Gaea Times at : Teva UK Limited Comments on Department of Health Generic Substitution Outcome.

Almac has Successful MHRA Inspection at its Clinical Services UK Site

CRAIGAVON, Northern Ireland, October 18, 2010 – Almac is once again pleased to announce the successful completion of an
inspection of its Clinical Services UK facility located in Craigavon by the
Medicines and Healthcare products Regulatory Agency (MHRA).

The routine inspection, which took place over four days, from September
13th – September 16th, was … Original source on Gaea Times at : Almac has Successful MHRA Inspection at its Clinical Services UK Site.

Enigma Diagnostics’ Patents Maintained by UK Intellectual Property Office

OXFORD, England, October 18, 2010 – Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced that the UK Intellectual Property Office (IPO)
has rejected a revocation action brought by Biogene against three patents
licensed exclusively to Enigma by the Defence Science and Technology
Laboratory (Dstl), part of the UK Ministry of Defence. The patents cover
electrically conducting …. Source article  : Enigma Diagnostics' Patents Maintained by UK Intellectual Property Office.

Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer

To support better radiation targeting accuracy, the Leeds Teaching Hospitals NHS Trust rolls out cutting-edge technology

LEEDS, England, October 18, 2010 – A 67-year-old female patient with lung cancer presented physicians with a
difficult challenge: her tumor was small and it rode up and down with her
breathing. During her treatment set up, all doctors saw on …. Original article  : Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer.

Optical Express Leads Eye-Opening Mission to Improve Syrian Eye Care

LONDON, October 18, 2010 – Four eye care volunteers journey to Syria to help those whose lives have
been blighted by poor eye sight.

Optical Express employees Amy McLaughlin, Jill Young, Jaymeet Patel and
Scott Mackie travelled from the UK to Western Asia to help treat patients as
part of Dr. Morhaf and the … Read this article on Gaea Times at : Optical Express Leads Eye-Opening Mission to Improve Syrian Eye Care.

Third Quarter 2010 Results Date Notification – October 29, 2010

DUBLIN, October 18, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce third quarter 2010 earnings on
Friday 29 October, 2010.

Results press release will be 12:00 BST / 07:00 EDT
issued at:
Investor conference call … Read more »»».

Shire Receives 2010 Prix Galien UK Award for FIRAZYR(R) (icatibant)

Not for Distribution to US Media
DUBLIN, October 18, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that it has been awarded the Prix
Galien UK Orphan Drug Medal for FIRAZYR (icatibant), a treatment for acute
attacks of hereditary angioedema (HAE). The award was presented at a ceremony
on October 13, 2010, …. Source article on Gaea Times at  : Shire Receives 2010 Prix Galien UK Award for FIRAZYR(R) (icatibant).

CSafe Signs Master Lease Agreement With Air Canada

AcuTemp(R) RKN to Enhance Cold Chain Distribution Offerings
DAYTON, Ohio, October 18, 2010 – CSafe, LLC, www.csafellc.com, manufacturer of the AcuTemp(R) RKN
active temperature controlled cargo container, and Air Canada,
www.aircanada.com, Canada's largest full-service airline have signed a
master lease agreement for CSafe's active temperature controlled containers.

The agreement enhances the Air Canada Cargo's AC …. Source article on Gaea Times at  : CSafe Signs Master Lease Agreement With Air Canada.

A Leading French Research Institute is Placing its Trust in FRT

CEA-LETI in Grenoble is Purchasing a Unique Wafer Metrology Solution
BERGISCH GLADBACH, Germany, October 18, 2010 – An internationally leading research institution in the microelectronics,
information and health technology industries is relying on surface metrology
from Germany. CEA-LETI will be working with a fully automatic wafer
inspection system, the FRT MFE (Metrology For Frontend). With this tool, FRT
has …. Original source  : A Leading French Research Institute is Placing its Trust in FRT.

Kraton Polymers Announces Plans to Showcase New Products Engineered for Higher Performance and Environmental Sustainability at The 18th International Trade Fair for Plastics and Rubber Worldwide (K 2010)

October 27-November 3, 2010, Dusseldorf, Germany
HOUSTON, October 19, 2010 – Kraton Performance Polymers, Inc. (NYSE: KRA), a leading global producer
of styrenic block copolymers or "SBCs," announces plans to exhibit at The
18th International Trade Fair for Plastics and Rubber Worldwide (K 2010),
from October 27-November 3, 2010 in Dusseldorf, Germany. The company plans to
showcase six of …. Source article  : Kraton Polymers Announces Plans to Showcase New Products Engineered for Higher Performance and Environmental Sustainability at The 18th International Trade Fair for Plastics and Rubber Worldwide (K 2010).

Biotec Introduces PRISYM Medica Labeling System

WOKINGHAM, England, October 19, 2010 – Biotec Services International Limited (Biotec) has introduced
a new labeling system to its clinical trials process to help manage complete
label production, become more efficient and reduce costs passed on to
clients.

The PRISYM Medica Labeling Software, which supports compliancy
with both EU and US regulatory requirements including FDA … Read more : Biotec Introduces PRISYM Medica Labeling System.

Abu Dhabi Takes Bold Strides as Center for Health Innovation with World Health Care Congress Middle East, December 5-7, 2010

ABU DHABI, United Arab Emirates, October 19, 2010 – Abu Dhabi, the capital of the United Arab Emirates, advances as a health
care innovation center this December as it hosts the World Health Care
Congress (WHCC) Middle East, a meeting of global health care stakeholders
that will share best practices for improving the delivery of high quality
cost-effective … Read more : Abu Dhabi Takes Bold Strides as Center for Health Innovation with World Health Care Congress Middle East, December 5-7, 2010.

Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research

REDWOOD CITY, California, October 19, 2010 – Ingenuity(R) Systems, the leading provider of information solutions for
life science researchers, and TransMed Systems, a translational medicine
software and services company, today announced an integration between IPA(R)
software and XB Bio-Integration Suite (XB-BIS). Researchers can now easily
take pre-clinical and clinical data that is managed and statistically
analyzed by XB-BIS, directly …. Original article  : Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research.

Stem Cell Assurance Announces Appointment of Mark Weinreb, M.S. as Chief Executive Officer and Board Member

BOCA RATON, Florida, October 19, 2010 – Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today the
appointment of Mark Weinreb as Chief Executive Officer and as a member of the
Company's Board of Directors. Mr. Weinreb is a well-recognized and respected
professional within the medical and financial communities.

Mr. Weinreb offers expertise in …. Read the original article  : Stem Cell Assurance Announces Appointment of Mark Weinreb, M.S. as Chief Executive Officer and Board Member.

In-demand Contemporary Research Reports on Biotechnology Markets Available at MCGroup.co.uk

LONDON, October 19, 2010 – Merchant Research & Consulting Ltd offers new cutting-edge market
research reports on Biotechnology now available at mcgroup.co.uk
(mcgroup.co.uk/researches).

Prions – Market Report (
mcgroup.co.uk/researches/P/24300/Prions%20-%20Market%20Report.html)
This report gives an insight into the market for Prion Deactivation
technologies, Post Mortem Testing for BSE and Prion Reduction Filters. The
Prion related products include BSE detection …. Read the original article  : In-demand Contemporary Research Reports on Biotechnology Markets Available at MCGroup.co.uk.

Agendia Establishes Contract with Humana to Cover MammaPrint

178m US Lives Covered by Adding Humana Contract for FDA-Cleared Breast Cancer Test

IRVINE, California and AMSTERDAM, October 19, 2010 – Agendia, a world leader in molecular cancer diagnostics,
announced today that it has established a contract with leading insurance
provider Humana to reimburse for the company's MammaPrint test. Agendia's
contract with Humana expands the coverage for MammaPrint …. Read the original article  : here.

Dipexium Pharmaceuticals Raises US$1.4 Million in Private Offering

NEW YORK, October 19, 2010 – Dipexium Pharmaceuticals today announced that it has raised aggregate
gross proceeds of US$1.4 million in a private offering of its Class A Member
Interests in a multiple-closing transaction commencing with the initial
closing on July 23, 2010. The Class A Member Interests were offered by the
Company at a price of US$50 … Original article on : Dipexium Pharmaceuticals Raises US$1.4 Million in Private Offering.

Frost & Sullivan Award Highlights Belimed Group’s Commitment to Customer Value Enhancement

LONDON, October 19, 2010 – The "2010 Frost & Sullivan European Infection Control Customer Value
Enhancement Award" was recently conferred on Belimed Group, one of the
leading companies in the European decontamination equipment market.
Innovative and high quality products, coupled with exceptional customer
services and key differentiating factors, are signals that Belimed performs
exceptionally well in this market. The …. Read the original article  : here.

Almac has Successful MHRA Inspection at its Clinical Services UK Site

CRAIGAVON, Northern Ireland, October 18, 2010 – Almac is once again pleased to announce the successful completion of an
inspection of its Clinical Services UK facility located in Craigavon by the
Medicines and Healthcare products Regulatory Agency (MHRA).

The routine inspection, which took place over four days, from September
13th – September 16th, was … Read more : Almac has Successful MHRA Inspection at its Clinical Services UK Site.

Cmed Technology’s New Timaeus 5 On-Demand eClinical Platform Focuses on Flexibility and Freedom

Also Unveils Timaeus HotSpot, Industry's First Portable eClinical Suite Demonstrating Regulatory Compliant Use with Apple iPad(R), Windows(R) Notebooks

MINNEAPOLIS and BERLIN, October 18, 2010 – Cmed Technology, an eClinical technology provider, today unveiled two
product previews at two major pharmaceutical conferences. It debuted Timaeus
5, Cmed's newest version of its unified eClinical platform to manage data
from Study … Read the original article on Gaea Times at : Cmed Technology's New Timaeus 5 On-Demand eClinical Platform Focuses on Flexibility and Freedom.

Liquent Announces Strategic Partnership with eSA, Inc.

New Alliance Strengthens Liquent's Presence in Japanese Market
HORSHAM, Pennsylvania, October 18, 2010 – Liquent, Inc. today announced it has entered into a strategic partnership
with eSA, Inc., a leading solutions provider for regulatory information
management and regulatory services within Asia. Through an exclusive
agreement, eSA will now have the commercial and technical support
responsibilities for Liquent's strategic offerings, … Read more >>.

Enigma Diagnostics’ Patents Maintained by UK Intellectual Property Office

OXFORD, England, October 18, 2010 – Enigma Diagnostics Limited, the decentralised and point-of-care molecular
diagnostics company, announced that the UK Intellectual Property Office (IPO)
has rejected a revocation action brought by Biogene against three patents
licensed exclusively to Enigma by the Defence Science and Technology
Laboratory (Dstl), part of the UK Ministry of Defence. The patents cover
electrically conducting …. Source  : Gaea News Network.

Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer

To support better radiation targeting accuracy, the Leeds Teaching Hospitals NHS Trust rolls out cutting-edge technology

LEEDS, England, October 18, 2010 – A 67-year-old female patient with lung cancer presented physicians with a
difficult challenge: her tumor was small and it rode up and down with her
breathing. During her treatment set up, all doctors saw on …. Source  : Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer.

Optical Express Leads Eye-Opening Mission to Improve Syrian Eye Care

LONDON, October 18, 2010 – Four eye care volunteers journey to Syria to help those whose lives have
been blighted by poor eye sight.

Optical Express employees Amy McLaughlin, Jill Young, Jaymeet Patel and
Scott Mackie travelled from the UK to Western Asia to help treat patients as
part of Dr. Morhaf and the …. Source article  : Optical Express Leads Eye-Opening Mission to Improve Syrian Eye Care.

Third Quarter 2010 Results Date Notification – October 29, 2010

DUBLIN, October 18, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce third quarter 2010 earnings on
Friday 29 October, 2010.

Results press release will be 12:00 BST / 07:00 EDT
issued at:
Investor conference call … Read the original article on Gaea Times at : Third Quarter 2010 Results Date Notification – October 29, 2010.

Shire Receives 2010 Prix Galien UK Award for FIRAZYR(R) (icatibant)

Not for Distribution to US Media
DUBLIN, October 18, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that it has been awarded the Prix
Galien UK Orphan Drug Medal for FIRAZYR (icatibant), a treatment for acute
attacks of hereditary angioedema (HAE). The award was presented at a ceremony
on October 13, 2010, …. Source  : Shire Receives 2010 Prix Galien UK Award for FIRAZYR(R) (icatibant).

CSafe Signs Master Lease Agreement With Air Canada

AcuTemp(R) RKN to Enhance Cold Chain Distribution Offerings
DAYTON, Ohio, October 18, 2010 – CSafe, LLC, www.csafellc.com, manufacturer of the AcuTemp(R) RKN
active temperature controlled cargo container, and Air Canada,
www.aircanada.com, Canada's largest full-service airline have signed a
master lease agreement for CSafe's active temperature controlled containers.

The agreement enhances the Air Canada Cargo's AC … Original article on : CSafe Signs Master Lease Agreement With Air Canada.

A Leading French Research Institute is Placing its Trust in FRT

CEA-LETI in Grenoble is Purchasing a Unique Wafer Metrology Solution
BERGISCH GLADBACH, Germany, October 18, 2010 – An internationally leading research institution in the microelectronics,
information and health technology industries is relying on surface metrology
from Germany. CEA-LETI will be working with a fully automatic wafer
inspection system, the FRT MFE (Metrology For Frontend). With this tool, FRT
has [..] Read the original article: here.

Kraton Polymers Announces Plans to Showcase New Products Engineered for Higher Performance and Environmental Sustainability at The 18th International Trade Fair for Plastics and Rubber Worldwide (K 2010)

October 27-November 3, 2010, Dusseldorf, Germany
HOUSTON, October 19, 2010 – Kraton Performance Polymers, Inc. (NYSE: KRA), a leading global producer
of styrenic block copolymers or "SBCs," announces plans to exhibit at The
18th International Trade Fair for Plastics and Rubber Worldwide (K 2010),
from October 27-November 3, 2010 in Dusseldorf, Germany. The company plans to
showcase six of … Original source on Gaea Times at : Kraton Polymers Announces Plans to Showcase New Products Engineered for Higher Performance and Environmental Sustainability at The 18th International Trade Fair for Plastics and Rubber Worldwide (K 2010).

UK Launch of Non-Surgical Medical Device Set to Tackle Epidemic of Diabetes & Obesity

LONDON, October 15, 2010 – Elemental Healthcare, a leading medical devices company that
specialises in providing products for non-surgical treatments, today
announced the UK launch of the EndoBarrier(TM) Gastrointestinal Liner.
EndoBarrier has been designed for people who struggle with the management of
Type 2 diabetes, of which over 2.5 million[i] people suffer in the UK, and
those who are … Read the original article on Gaea Times at : UK Launch of Non-Surgical Medical Device Set to Tackle Epidemic of Diabetes & Obesity.

Elsevier / MC Strategies and Association of periOperative Registered Nurses (AORN) Launch Perioperative Nursing Skills Collection

New Evidence-based Procedures Series Latest in Mosby's Nursing Skills
ATLANTA, Georgia, October 20, 2010 – Elsevier / MC Strategies (www.mcstrategies.com/), a
pioneer in providing e-learning solutions to more than 1,300 healthcare
organizations, has partnered with the Association of periOperative Registered
Nurses (AORN) to develop the latest module for Mosby's Nursing Skills:
Perioperative Collection, the only perioperative-specific set of nursing
skills … Original article on : Elsevier / MC Strategies and Association of periOperative Registered Nurses (AORN) Launch Perioperative Nursing Skills Collection.

JIPH Accepted for MEDLINE Indexing

JIPH the First of Elsevier's Middle East Titles to be Selected for MEDLINE Indexing

AMMAN, Jordan, October 20, 2010 – Elsevier Middle East announces that the Journal of Infection and Public
Health (JIPH) has been selected for inclusion in MEDLINE, the premier
bibliographic database of the U.S. National Library of Medicine (NLM).
Citations for articles indexed, the indexing …. Original source  : JIPH Accepted for MEDLINE Indexing.

Abbott Reports Strong Third Quarter Results; Confirms Double-Digit Ongoing Earnings Outlook for 2010

Third Quarter Ongoing EPS Growth of 14.1 Percent -
ABBOTT PARK, Illinois, October 20, 2010 – Abbott (NYSE: ABT) today announced financial results for the third
quarter ended Sept. 30, 2010.

– Diluted earnings per share, excluding specified items, were
US$1.05, reflecting 14.1 percent growth, at the high …. Source  : Abbott Reports Strong Third Quarter Results; Confirms Double-Digit Ongoing Earnings Outlook for 2010.

Cheetah Medical Announces European Launch of a New NICOM(R) System for Advanced Noninvasive Hemodynamic Monitoring and Fluid Management

Cheetah's Noninvasive Hemodynamic Monitoring System now Available With Integrated Pulse Oxymetry and Oxygen Delivery Functionality to Expedite Fluid Optimization, Goal-Directed Therapy and Comprehensive Hemodynamic Management

TEL AVIV, Israel, October 15, 2010 – Cheetah Medical today announced the European launch of its new
NICOM(R) System which offers an integrated Pulse Oximetry functionality
(OxiMax(R) Covidien plc). In addition to …. Source  : Gaea News Network.

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

Phase III TEMSO Study Meets Goals Including Delayed Disability Progression for Teriflunomide 14mg

PARIS, October 15, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the results
from the two year phase III TEMSO study of teriflunomide, a novel oral
disease modifier investigated for the treatment of relapsing multiple
sclerosis (RMS). In this study, both doses of … Read : Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients.

Essilor to Acquire 50% of Shamir Optical

KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, October 15, 2010 – Shamir Optical Industry Ltd. (Nasdaq: SHMR) ("Shamir
Optical"), Kibbutz Shamir and Essilor International (NYSE Euronext: EI)
("Essilor") today announced that they have signed an agreement whereby
Essilor will, through a series of transactions, acquire 50% of Shamir
Optical. As a result of these transactions, Kibbutz Shamir and Essilor … Original article on : Essilor to Acquire 50% of Shamir Optical.

A New BioPharma Intelligence Resource Set to Give Industry Leaders the Edge

OXFORD, England, October 21, 2010 – In the current BioPharma economic climate; with smaller
companies desperately needing the right development partners for survival and
larger ones needing to support their existing businesses through making the
right deals, having the best, most comprehensive, intelligence and insights
are absolutely essential for success.

It is into this environment … Read more : A New BioPharma Intelligence Resource Set to Give Industry Leaders the Edge.

Mammography Clinic Takes up the Fight Against Osteoporosis

Combining Low Dose Mammography and new Online Service From Sectra
LINK??PING, Sweden, October 21, 2010 – Sectra announces an agreement with Aspen Healthcare Ltd for use of
Sectra's unique solution for mammography and osteoporosis screening at Holly
House Hospital. The hospital is the first in the UK to give women the
opportunity of better quality of life by …. Source  : Gaea News Network.

IDEV Technologies Launches Additional Products in Europe

New Sizes of SUPERA(R) Stent Expand Treatment Options for Peripheral Vascular Disease

WEBSTER, Texas, October 21, 2010 – IDEV Technologies, Incorporated (IDEV), an innovative leader in the
development and commercialization of minimally invasive medical technologies,
today announced another step in the implementation of its strategy to expand
its product line for treating patients with peripheral vascular disease with
the …. Original article on Gaea Times at  : IDEV Technologies Launches Additional Products in Europe.

Protecting Women’s Health in Long-Term Partnership

LONDON, October 21, 2010 – OCS Group CEO Chris Cracknell and Conrad Mielcuszny, CEO of
Genesis Biosciences, have signed a long-term agreement continuing the
exclusive use of the ground breaking germicide Activap(TM) in Cannon Hygiene
(part of the OCS Group) feminine hygiene units. Activap(TM) is the world's
most advanced, proven effective in-use germicide for feminine hygiene waste
disposal. Results … Read more >>.

New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia

Findings From Largest MRSA Nosocomial Pneumonia Study Conducted to Date Were Presented During IDSA Annual Meeting

NEW YORK, October 21, 2010 – Results of a new international phase 4 study of patients with nosocomial
pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA)
demonstrated that the antibiotic Zyvox(R) (linezolid) achieved a
statistically significantly higher clinical success rate compared with
vancomycin …. Source article  : New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia.

The British Association of Cosmetic Doctors Launches the UK’s First Post Graduate Diploma in Cosmetic Medicine

Setting the Standard for Cosmetic Medical Treatments
LONDON, October 21, 2010 – The British Association of Cosmetic Doctors has launched the
first Post Graduate Diploma in Cosmetic Medicine specifically for doctors
through Leicester Medical School. This is the only qualification specifically
related to medical cosmetics and accredited by a medical school. With an
estimated 1 million* injectable cosmetic treatments … Read more >>>.

Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix(TM) Biliary Stents

Latest Innovation in Plastic Biliary Stent Technology Includes Features for Enhanced Deliverability, Efficiency and Procedural Control

NATICK, Massachusetts, October 21, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that it has
received 510(k) clearance from the U.S. Food and Drug Administration and CE
Mark approval to market its Advanix(TM) Biliary Plastic Stents for the
treatment of biliary … Read the original article on Gaea Times at : Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix(TM) Biliary Stents.

Lloydspharmacy Reports Young Brits’ Blood Pressure Rising

COVENTRY, England, October 21, 2010 – Lloydspharmacy has announced the publication of a new study that reveals
35 per cent of 16-34 year olds had high blood pressure readings.

The study, which involved 8568 people over the age of 16, showed that
only one in four had an ideal or normal blood pressure …. Source article  : Lloydspharmacy Reports Young Brits' Blood Pressure Rising.

Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical

JENA, Germany, October 22, 2010 – Occlutech GmbH, the leading European developer of minimally invasive
implants for the treatment of structural heart disease, today announced
receiving a favourable appeal court ruling from The Hague, The Netherlands in
the on-going patent litigation with AGA Medical. A favourable first instance
court ruling obtained by Occlutech had been appealed by AGA …. Original article  : Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical.

Public Health Agency: 1970s Technology Puts us all at Deadly Legionnaires’ Risk?

DERBY, England, October 22, 2010 – With no culprit yet announced following the recent fatal outbreak of
Legionnaires' disease through the South Wales Valleys, questions are being
raised about old machinery putting our health at risk. In August the disease
left twenty victims in hospital and claimed two fatalities. Authorities'
investigations have centred on water treatment plants in … Read more : Public Health Agency: 1970s Technology Puts us all at Deadly Legionnaires' Risk?.

700 Companies With 1.400 Participants Attend BioSpain 2010

MADRID, October 22, 2010 – The Spanish Bioindustry Association (ASEBIO) and the Navarre
Society of Development (Sodena), under the Government of Navarre, celebrated
BioSpain 2010 in Pamplona, from September 29th to October 1st where
attendance was over 1.400 participants.

This event hosted about 2.200 business meetings, through the
partnering system, among 700 companies, of which …. Source  : 700 Companies With 1.400 Participants Attend BioSpain 2010.

Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of the Disease

Study Met its Primary Endpoint
GENEVA, October 25, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that the two-year Phase III REFLEX 1 study met its primary
endpoint by demonstrating that Rebif(R) (interferon beta-1a) significantly
delayed conversion to multiple sclerosis (MS) diagnosed according to the
McDonald criteria 2 in patients with a first clinical … Read more »».

Non-communicable Diseases Mortality to Cost a Whopping USD237 Billion to the National Income by 2015

Experts Say Universal Access to Preventive and Curative Intervention is Crucial

NEW DELHI, October 25, 2010 – Health experts participating at a roundtable organised by India Health
Progress(IHP) on economic and social impact of non-communicable diseases in
India are of the opinion that a concerted effort is required to address the
growing burden.
A review …. Original article  : Non-communicable Diseases Mortality to Cost a Whopping USD237 Billion to the National Income by 2015.

MarketsandMarkets New Report – Global Ophthalmology Drugs & Devices Market

DALLAS, October 25, 2010 – Read The Complete TOC Here:
www.marketsandmarkets.com/Market-Reports/ophthalmology-drugs-devices-2
18.html

Global ophthalmology drug and devices market is witnessing a significant
growth due to the increasing incidence and prevalence of eye related
disorders such as presbyopia, macular degeneration, and diabetic retinopathy
among the aging population. With the introduction of ophthalmic devices
equipped with sophisticated technologies, people … Original source on Gaea Times at : MarketsandMarkets New Report – Global Ophthalmology Drugs & Devices Market.

Elsevier Introduces Protein Viewer, Bringing Science to Life

New Feature on SciVerse ScienceDirect Presents Proteins in Three Dimensions, Allowing Manipulation of Molecular Structures, to the Benefit of the Reader

AMSTERDAM, October 25, 2010 – Elsevier, a world-leading publisher of scientific, medical and technical
products and services, introduces Protein Viewer, a new, interactive feature
on SciVerse ScienceDirect for the Journal of Molecular Biology (JMB)
(www.sciencedirect.com/science/journal/00222836). With Protein … Original article on : Elsevier Introduces Protein Viewer, Bringing Science to Life.

Positive Results From LigoCyte’s Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting

Intranasal Norovirus VLP Vaccine Demonstrates Clinical Efficacy When Compared to Placebo in Phase I/II Trial

BOZEMAN, Montana, October 25, 2010 – LigoCyte Pharmaceuticals, Inc., a private, clinical-stage
biopharmaceuticals company developing innovative vaccine products, today
announced positive results from a Phase I/II challenge study of its norovirus
virus-like particle (VLP) vaccine candidate. Baylor College of Medicine's
Robert Atmar, M.D., the …. Read the original article  : Positive Results From LigoCyte's Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting.

Infosys Science Foundation Announces Winners of the Infosys Prize 2010

Winners to be Awarded Rs.50 lakh in Recognition of Their Outstanding Contributions to Scientific Research

BANGALORE, India, October 25, 2010 – The Infosys Science Foundation today announced the winners of
the Infosys Prize 2010 recognizing outstanding contributions to scientific
research that have impacted India. The winners across five categories -
Mathematical Sciences, Physical Sciences, Engineering and Computer Science,
Life …. Source  : Infosys Science Foundation Announces Winners of the Infosys Prize 2010.

PharmaVentures Acts as Advisor and Broker to Dr Reddy’s to Identify and Secure Product Marketing Opportunities for the Russian/CIS Market

OXFORD, England, October 26, 2010 – PharmaVentures Ltd announced today that it had acted as the advisor and
broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its
successful marketing and distribution agreement with the UK healthcare
company Vitabiotics Ltd for a range of nutraceutical products. The agreement
provides Dr Reddy's exclusive marketing rights in the Russian/CIS [..] Read the original article: here.

Shire Receives INTUNIV(TM) Paragraph IV Notice Letter

Watson is the Fourth Paragraph IV Filer Against INTUNIV
DUBLIN, October 26, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that it has received a Paragraph IV
Notice Letter from Watson Laboratories, Inc. ("Watson") advising of the
filing of an Abbreviated New Drug Application ("ANDA") for a generic version
of Shire's 4 mg … Read the original article on Gaea Times at : Shire Receives INTUNIV(TM) Paragraph IV Notice Letter.

Bupa Report Reveals That Half of all UK Parents Send Children To School When Ill

LONDON, October 26, 2010 – Bupa has revealed that fever, diarrhoea or vomiting are not enough to
stop British parents sending their offspring to school. New research from the
Bupa 'How Are You Britain?' report reveals half of all parents in the UK
admit to sending their children to school or nursery when they are feeling
poorly and … Read more »».

Sirius Genomics Announces Issuance of U.S. Patent

VANCOUVER, October 26, 2010 – Sirius Genomics, a developer of companion diagnostics, announced today
that U.S. Patent No. 7,820,376 entitled "Protein C Polymorphisms" has been
issued by the United States Patent and Trademark Office. The patent relates
to a novel use of a Single Nucleotide Polymorphism (SNP) located in the
Protein C gene.

"The patent …. Original source  : Sirius Genomics Announces Issuance of U.S. Patent.

Henry Schein Enters Fast-Growing Dental Market in Turkey

Full-Service Distributor Holds a Leading Market Position
MELVILLE, New York, October 27, 2010 – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care
products and services to office-based practitioners, today announced it has
acquired a 50% non-consolidating interest in Guney Dis Deposu (Guney), a
full-service dental distribution business headquartered in Istanbul, Turkey.
The remaining 50% will be …. Source  : Henry Schein Enters Fast-Growing Dental Market in Turkey.

Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research

Tribute Website Provides Laureate Research on In-Vitro Fertilization, Revolutionary Processes in Physics and Chemistry, and Labor and Housing Market Theory

AMSTERDAM, October 27, 2010 – Elsevier, the leading scientific, technical and medical
publisher announced today the launch of a Nobel tribute website
(www.elsevier.com/nobel) to honor nine 2010 Nobel laureates and
provide free access to their research published by …. Read the original article  : here.

Torchmark Corporation Reports Third Quarter 2010 Results

MCKINNEY, Texas, October 27, 2010 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended September 30, 2010, net income was $1.41 per share compared with $1.22
per share for the year-ago quarter. Net operating income for the quarter was
$1.63 per share, a 10% per share increase compared with $1.48 per share for
the year-ago …. Read the original article  : here.

Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact

CHICAGO, October 29, 2010 – New data presented today at The 2010 European Headache and Migraine Trust
International Congress (EHMTIC) shows that persons with chronic migraine
(headache on greater than or equal to 15 days per month) are much more likely
to have annual household incomes below US$30,000 than those with episodic
migraine (headache on < 15 days …. Source article  : Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact.

Doctor to World Community: Eat Right and Thrive!

Joel Fuhrman, M.D., To Offer Message of Hope and Healing at London Scientific Conference

LONDON, October 28, 2010 – Joel Fuhrman, M.D., a world leader in nutritional science, will share his
discoveries leading to permanent weight loss and the reversal of chronic
health conditions such as heart disease, diabetes and high blood pressure now
threatening the world community …. Original source  : Doctor to World Community: Eat Right and Thrive!.

Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)

LONDON, October 28, 2010 – Diabetic Hypoglycemia supports World Diabetes Day on the 14th November
2010 in raising the global awareness of diabetes (
www.worlddiabetesday.org/).

The theme of World Diabetes Day in 2010 is "Let's take control of
diabetes. Now", which marks the second year of the five-year focus on
diabetes education and prevention, the …. Source  : Taking Control of Diabetes: Support World Diabetes Day (14th November 2010).

Merck Serono Sells Th??ramex to Teva for EUR 265 Million

Acquisition Will Provide Teva With a Strong Platform to Expand its Global Women's Health Business

GENEVA, October 28, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that it will sell Th??ramex, its Monaco-based pharmaceutical
company specialized in women's health and gynecology, to Teva. Merck KGaA and
Teva have signed an agreement whereby Teva …. Original article on Gaea Times at  : Merck Serono Sells Th??ramex to Teva for EUR 265 Million.

Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist

Potential Therapy for Lung Fibrosis of Scleroderma and Idiopathic Pulmonary Fibrosis

SAN DIEGO, October 28, 2010 – Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase
1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy
subjects.
"We are excited to begin our journey exploring the therapeutic value of
AM152, a …. Original source  : Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist.

Pfizer’s Lyrica(R) (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan

First Treatment Approved for Common Pain Conditions Filling Important Unmet Need for Patients in Japan

NEW YORK, October 28, 2010 – Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of
Health, Labour and Welfare approved Lyrica(R) (pregabalin) capsules for the
treatment of peripheral neuropathic pain. This follows the recent approval in
Japan of Lyrica for the treatment … Read more >>.

Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder

PHILADELPHIA, October 29, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced results from a Phase 2 signal
finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in
patients who have had residual symptoms of depression following treatment
with LEXAPRO(R) (escitlopram) for Major Depressive Disorder (MDD). Based on
these findings, Shire intends to advance …. Source article  : Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder.

Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging

DUBLIN, October 29, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company, announces results for the three months to
September 30, 2010.

Financial Highlights … Read the original article on Gaea Times at : Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging.